InvestorsHub Logo
Followers 1053
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: tjguy post# 953

Thursday, 08/10/2017 7:38:58 AM

Thursday, August 10, 2017 7:38:58 AM

Post# of 3504
Please read zino post. April 17, 2017 07:36 ET

Cleveland BioLabs Announces Commencement of In Vivo Biocomparability Study

Mentioned the 9.2m Dod's contract. But company working on other drugs too and and there are more 0-4 months ahead catalysts too. First MMA updates ( Europe) expect anytime per last 8-K and more phase 2 catalyst till Jan 2018 per my understanding
I posted full DD a while ago mentioned those updates as well as the positive opinion from both EMA and FDA back in April 2017. What makes it a safe holding ( beside the Blockbaster rafiation drug) is a strong cash on hand ( fully funded a year ahead per last 10Q) and the solid balance sheet a/o today. almost zero debt.

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.